02 Jan 2026 | 07:00
Director/PDMR Shareholding
/**/
RNS Number : 3624N Adnams PLC 02 January 2026
Adnams plc
("Adnams" or the "Company")
Director Dealing
The Company announces that it has received notification that on 31 December 2025 Jennifer Hanlon, Chief Executive Officer and Director of the Company, purchased, into a Self-Invested Personal Pension, 1,051 B Ordinary Shares ("B Shares") in the Company at a price of £19.00 per share.
As a result of this purchase, Mrs Hanlon's total beneficial interest in the Company's shares is 1,151 B Shares in the Company, which represent 0.112% of the total voting rights of the Company.
Enquiries: For further information please contact info@adnams.co.uk
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 - Details of the person discharging managerial responsibilities / person closely associated
Name of natural person
Jennifer Hanlon
Legal Person
2 - Reason for the notification
Position/status
Chief Executive Officer / Director
Initial notification/amendment
Initial Notification
3 - Details of the issuer or emission allowance market participant
Full name of the entity
Adnams plc
Legal Entity Identifier Code
213800LRWL8Q9JP1QQ05
4 - Details of the transaction(s)
Date of transaction
31 December 2025
Financial Instrument
B Ordinary Shares of £1.00 each
Identification Code
GB0000075845
Place of the transaction
AQSE Access Market
Currency
GBP - British Pound
Nature of the transaction
Purchase of B Ordinary Shares into a Self-Invested Personal Pension
Price(s) and Volume(s)
Price
Volume
Total
19.00
1051
19969.00
Aggregated
19.00
1051
19969.00
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NEXWPGUUPUPAGQG